Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01804686
Title A Long-term Extension Study of PCI-32765 (Ibrutinib)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia



Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.